Aemetis extends $118.8M ABGL redemption; sets high-rate backstop

Aemetis, Inc. disclosed that subsidiary Aemetis Biogas LLC (ABGL) executed a Tenth Waiver and Amendment to its Series A Preferred Unit Purchase Agreement with Protair-X Technologies Inc. and Third Eye Capital, effective August 31, 2025.

Rhea-AI Filing Summary

Aemetis, Inc. disclosed that subsidiary Aemetis Biogas LLC (ABGL) executed a Tenth Waiver and Amendment to its Series A Preferred Unit Purchase Agreement with Protair-X Technologies Inc. and Third Eye Capital, effective August 31, 2025. The amendment extends ABGL’s deadline to redeem all outstanding Series A Preferred Units from August 31, 2025 to December 31, 2025 and sets the aggregate redemption price at $118.8 million, which includes a $2 million amendment fee.

If ABGL does not redeem by the new deadline, it will enter a Credit Agreement in substantially the attached form, effective January 1, 2026, maturing September 1, 2026, with interest at the greater of 16.0% or the prime rate plus 10.0%. The agreement would require guarantees from Aemetis, Inc. and certain subsidiaries and grant security interests in the assets of ABGL and the guarantors. Protair-X currently owns 100% of ABGL’s Series A Preferred Units.

Insights

Credit & Capital Structure Analyst

Redemption extended; costly secured backstop in place if unpaid.

The amendment pushes ABGL’s full redemption of the Holder’s preferred units to December 31, 2025 and fixes the redemption at $118.8 million, including a $2 million fee. This clarifies the amount and near-term timing tied to the preferred capital.

If redemption does not occur, a Credit Agreement takes effect on January 1, 2026 with a maturity on September 1, 2026. The rate is the greater of 16.0% or prime plus 10.0%, and obligations are guaranteed by Aemetis, Inc. and certain subsidiaries, secured by assets of ABGL and the guarantors.

This structure introduces a defined, high-cost contingency. Actual impact depends on whether ABGL completes the redemption by December 31, 2025 or transitions into the backstop credit terms thereafter.

8-K Event Classification

2 items: 1.01, 9.01

2 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

What did Aemetis (AMTX) change regarding ABGL’s preferred unit redemption?

ABGL’s redemption deadline moved to December 31, 2025 and the aggregate redemption price was set at $118.8 million, including a $2 million amendment fee.

What happens if ABGL does not redeem the preferred units by December 31, 2025?

ABGL will enter a Credit Agreement, effective January 1, 2026, satisfying the redemption obligation.

What are the key terms of the potential Credit Agreement for AMTX’s ABGL?

Effective January 1, 2026, maturing September 1, 2026, interest at the greater of 16.0% or prime + 10.0%, guaranteed by Aemetis and certain subsidiaries, secured by assets.

Who holds ABGL’s Series A Preferred Units under the amended agreement?

Protair-X Technologies Inc. owns 100% of the Series A Preferred Units; Third Eye Capital acts as agent.

What is the total redemption amount under the amended terms?

The aggregate redemption price is $118.8 million, which includes a $2 million fee for the amendment.

What collateral and support secure the potential Credit Agreement?

A security interest in assets of ABGL and the guarantors, with guarantees from Aemetis, Inc. and certain subsidiaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/21/2025 - 05:02 PM Learn about SEC filing dates

false 0000738214 0000738214 2025-10-15 2025-10-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 15, 2025

Aemetis, Inc.

Exact name of registrant as specified in its charter

Delaware	001-36475	26-1407544
State or other jurisdiction of incorporation	Commission File Number	IRS Employer Identification Number

20400 Stevens Creek Blvd., Suite 700

Cupertino, CA 95014

(408) 213-0940

Registrant's address and telephone number of principal executive office

N/A

Former name or former address, if changed since last report

Common Stock, par value $0.001	AMTX	NASDAQ Global Market
Title of class of registered securities	Trading Symbol	Name of exchange on which registered

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

☐ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter)

☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 1.01  Entry into a Material Definitive Agreement.

On October 15, 2025, Aemetis Biogas LLC ("ABGL"), a subsidiary of Aemetis, Inc., entered into an agreement, effective as of August 31, 2025, entitled Tenth Waiver and Amendment to Series A Preferred Unit Purchase Agreement ("PUPA Tenth Amendment"), with Protair-X Technologies Inc. ("Holder") and Third Eye Capital Corporation, as agent for the Holder. The Holder owns 100% of the Series A Preferred Units of ABGL (the "Preferred Units") pursuant to the original Series A Preferred Unit Purchase Agreement dated December 20, 2018, and its subsequent amendments. The PUPA Tenth Amendment provides, among other provisions, (i) an extension of ABGL's existing requirement to redeem all of the Holder's outstanding Series A Preferred Units from August 31, 2025, to December 31, 2025 (the "Redemption Date"), and (ii) a modification to the aggregate redemption price to $118.8 million, which includes a $2 million fee increase for the PUPA Tenth Amendment. The PUPA Tenth Amendment further provides that if ABGL does not redeem the Preferred Units by the Redemption Date, ABGL will enter into a credit agreement with Protair-X and Third Eye Capital, in substantially the form attached to the PUPA Tenth Amendment (the "Credit Agreement"), which entry would satisfy ABGL's redemption obligation. Once the Credit Agreement is entered, its key terms would include: (i) an effective date of January 1, 2026, (ii) a maturity date of September 1, 2026, (iii) accruing interest at a rate equal to the greater of 16.0% and the prime rate plus 10.0%, (iv) a requirement for Aemetis, Inc. and several of its subsidiaries (the "Guarantors") to guarantee ABGL's obligations, and (v) a grant of a security interest in the assets of ABGL and the Guarantors.

The foregoing summary of the material terms of the PUPA Tenth Amendment is qualified in its entirety by reference to the full text of the agreement filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01  Financial Statements and Exhibits.

(d) Exhibits.

10.1	Tenth Waiver and Amendment to Series A Preferred Unit Purchase Agreement, by and between Aemetis Biogas LLC, Protair-X Technologies Inc., and Third Capital Corporation (effective as of August 31, 2025)
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

	Aemetis, Inc.
October 21, 2025	/s/ Eric A. McAfee
	Eric A. McAfee
	Chairman and Chief Executive Officer